Inflection Point Acquisition Corp. V (IPEXR) Stock Competitors & Peer Comparison
See (IPEXR) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Conglomerates Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IPEXR | $0.66 | +20.15% | 183.7M | N/A | N/A | N/A |
| TPGXL | $22.73 | -2.24% | 21.4B | N/A | N/A | +5.45% |
| VOYA | $86.69 | +3.28% | 7.9B | 13.10 | $6.62 | +2.16% |
| VOYA-PB | $23.70 | -0.42% | 7.2B | 2.81 | $8.44 | +2.16% |
| BIPH | $16.34 | -0.63% | 6B | N/A | N/A | +7.65% |
| PACS | $37.01 | -1.23% | 5.9B | 23.89 | $1.55 | N/A |
| BBCQW | $2.48 | -11.43% | 1.4B | N/A | N/A | N/A |
| MSDL | $15.15 | -2.19% | 1.3B | 15.00 | $1.01 | +12.88% |
| RILYK | $25.23 | +0.16% | 787.6M | N/A | N/A | N/A |
| RILYN | $24.91 | +0.00% | 778.3M | N/A | N/A | N/A |
Stock Comparison
IPEXR vs TPGXL Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, TPGXL has a market cap of 21.4B. Regarding current trading prices, IPEXR is priced at $0.66, while TPGXL trades at $22.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TPGXL's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TPGXL's ROE of +0.13%. Regarding short-term risk, IPEXR is less volatile compared to TPGXL. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check TPGXL's competition here
IPEXR vs VOYA Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, VOYA has a market cap of 7.9B. Regarding current trading prices, IPEXR is priced at $0.66, while VOYA trades at $86.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas VOYA's P/E ratio is 13.10. In terms of profitability, IPEXR's ROE is +0.02%, compared to VOYA's ROE of +0.14%. Regarding short-term risk, IPEXR is less volatile compared to VOYA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check VOYA's competition here
IPEXR vs VOYA-PB Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, VOYA-PB has a market cap of 7.2B. Regarding current trading prices, IPEXR is priced at $0.66, while VOYA-PB trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas VOYA-PB's P/E ratio is 2.81. In terms of profitability, IPEXR's ROE is +0.02%, compared to VOYA-PB's ROE of +0.14%. Regarding short-term risk, IPEXR is less volatile compared to VOYA-PB. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check VOYA-PB's competition here
IPEXR vs BIPH Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, BIPH has a market cap of 6B. Regarding current trading prices, IPEXR is priced at $0.66, while BIPH trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BIPH's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BIPH's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to BIPH. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BIPH's competition here
IPEXR vs PACS Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PACS has a market cap of 5.9B. Regarding current trading prices, IPEXR is priced at $0.66, while PACS trades at $37.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PACS's P/E ratio is 23.89. In terms of profitability, IPEXR's ROE is +0.02%, compared to PACS's ROE of +0.27%. Regarding short-term risk, IPEXR is less volatile compared to PACS. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PACS's competition here
IPEXR vs BBCQW Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, BBCQW has a market cap of 1.4B. Regarding current trading prices, IPEXR is priced at $0.66, while BBCQW trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BBCQW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BBCQW's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to BBCQW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BBCQW's competition here
IPEXR vs MSDL Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, MSDL has a market cap of 1.3B. Regarding current trading prices, IPEXR is priced at $0.66, while MSDL trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MSDL's P/E ratio is 15.00. In terms of profitability, IPEXR's ROE is +0.02%, compared to MSDL's ROE of +0.05%. Regarding short-term risk, IPEXR is less volatile compared to MSDL. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MSDL's competition here
IPEXR vs RILYK Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYK trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYK's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYK's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYK. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYK's competition here
IPEXR vs RILYN Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYN has a market cap of 778.3M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYN trades at $24.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYN's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYN. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYN's competition here
IPEXR vs RILYG Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYG has a market cap of 768.6M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYG trades at $24.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYG's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYG's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYG. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYG's competition here
IPEXR vs RILYM Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYM trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYM's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYM's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYM. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYM's competition here
IPEXR vs RILYT Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYT has a market cap of 668.1M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYT trades at $21.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYT's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYT's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYT. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYT's competition here
IPEXR vs RILYO Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYO trades at $25.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYO's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYO's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYO. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYO's competition here
IPEXR vs RILYP Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYP has a market cap of 523.6M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYP trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYP's P/E ratio is 2.82. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYP's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYP. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYP's competition here
IPEXR vs RILYL Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILYL has a market cap of 515.6M. Regarding current trading prices, IPEXR is priced at $0.66, while RILYL trades at $16.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYL's P/E ratio is 2.78. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYL's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILYL. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYL's competition here
IPEXR vs NWAX Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, NWAX has a market cap of 509.2M. Regarding current trading prices, IPEXR is priced at $0.66, while NWAX trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NWAX's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to NWAX's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to NWAX. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check NWAX's competition here
IPEXR vs CRAN Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CRAN has a market cap of 472.3M. Regarding current trading prices, IPEXR is priced at $0.66, while CRAN trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CRAN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CRAN's ROE of +0.01%. Regarding short-term risk, IPEXR and CRAN have similar daily volatility (0.00).Check CRAN's competition here
IPEXR vs DBCAU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, DBCAU has a market cap of 439.4M. Regarding current trading prices, IPEXR is priced at $0.66, while DBCAU trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DBCAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DBCAU's ROE of N/A. Regarding short-term risk, IPEXR and DBCAU have similar daily volatility (0.00).Check DBCAU's competition here
IPEXR vs CCXIU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CCXIU has a market cap of 433.2M. Regarding current trading prices, IPEXR is priced at $0.66, while CCXIU trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CCXIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CCXIU's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to CCXIU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CCXIU's competition here
IPEXR vs CCXI Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CCXI has a market cap of 431.2M. Regarding current trading prices, IPEXR is priced at $0.66, while CCXI trades at $10.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CCXI's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CCXI's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to CCXI. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CCXI's competition here
IPEXR vs BBCQ Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, BBCQ has a market cap of 403.6M. Regarding current trading prices, IPEXR is priced at $0.66, while BBCQ trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BBCQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BBCQ's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to BBCQ. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BBCQ's competition here
IPEXR vs ANSCU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ANSCU has a market cap of 391.9M. Regarding current trading prices, IPEXR is priced at $0.66, while ANSCU trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ANSCU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ANSCU's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to ANSCU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ANSCU's competition here
IPEXR vs PLMKW Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PLMKW has a market cap of 370.6M. Regarding current trading prices, IPEXR is priced at $0.66, while PLMKW trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PLMKW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PLMKW's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to PLMKW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PLMKW's competition here
IPEXR vs CXIIU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CXIIU has a market cap of 369M. Regarding current trading prices, IPEXR is priced at $0.66, while CXIIU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CXIIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CXIIU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to CXIIU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CXIIU's competition here
IPEXR vs NWAX-UN Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, NWAX-UN has a market cap of 365.4M. Regarding current trading prices, IPEXR is priced at $0.66, while NWAX-UN trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NWAX-UN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to NWAX-UN's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to NWAX-UN. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check NWAX-UN's competition here
IPEXR vs CRANU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CRANU has a market cap of 361.8M. Regarding current trading prices, IPEXR is priced at $0.66, while CRANU trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CRANU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CRANU's ROE of +0.01%. Regarding short-term risk, IPEXR and CRANU have similar daily volatility (0.00).Check CRANU's competition here
IPEXR vs ARCI Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ARCI has a market cap of 351.9M. Regarding current trading prices, IPEXR is priced at $0.66, while ARCI trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ARCI's P/E ratio is -4339.13. In terms of profitability, IPEXR's ROE is +0.02%, compared to ARCI's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to ARCI. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ARCI's competition here
IPEXR vs SBXE Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SBXE has a market cap of 348.1M. Regarding current trading prices, IPEXR is priced at $0.66, while SBXE trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SBXE's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SBXE's ROE of -0.03%. Regarding short-term risk, IPEXR and SBXE have similar daily volatility (0.00).Check SBXE's competition here
IPEXR vs RREV Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RREV has a market cap of 333M. Regarding current trading prices, IPEXR is priced at $0.66, while RREV trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RREV's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RREV's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to RREV. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RREV's competition here
IPEXR vs RILY Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, RILY has a market cap of 314.5M. Regarding current trading prices, IPEXR is priced at $0.66, while RILY trades at $8.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILY's P/E ratio is 0.58. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILY's ROE of -2.63%. Regarding short-term risk, IPEXR is less volatile compared to RILY. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILY's competition here
IPEXR vs SAC Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SAC has a market cap of 314.3M. Regarding current trading prices, IPEXR is priced at $0.66, while SAC trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAC's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to SAC. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SAC's competition here
IPEXR vs DBCA Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, DBCA has a market cap of 308.6M. Regarding current trading prices, IPEXR is priced at $0.66, while DBCA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DBCA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DBCA's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to DBCA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DBCA's competition here
IPEXR vs KBONU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, KBONU has a market cap of 308.1M. Regarding current trading prices, IPEXR is priced at $0.66, while KBONU trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas KBONU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to KBONU's ROE of +0.01%. Regarding short-term risk, IPEXR and KBONU have similar daily volatility (0.00).Check KBONU's competition here
IPEXR vs ENHA Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ENHA has a market cap of 307.4M. Regarding current trading prices, IPEXR is priced at $0.66, while ENHA trades at $2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ENHA's P/E ratio is -7.62. In terms of profitability, IPEXR's ROE is +0.02%, compared to ENHA's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to ENHA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ENHA's competition here
IPEXR vs ALOVU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ALOVU has a market cap of 303.2M. Regarding current trading prices, IPEXR is priced at $0.66, while ALOVU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ALOVU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ALOVU's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to ALOVU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ALOVU's competition here
IPEXR vs PLMKU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PLMKU has a market cap of 296.9M. Regarding current trading prices, IPEXR is priced at $0.66, while PLMKU trades at $10.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PLMKU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PLMKU's ROE of +0.03%. Regarding short-term risk, IPEXR and PLMKU have similar daily volatility (0.00).Check PLMKU's competition here
IPEXR vs CAIIU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CAIIU has a market cap of 294.2M. Regarding current trading prices, IPEXR is priced at $0.66, while CAIIU trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CAIIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CAIIU's ROE of N/A. Regarding short-term risk, IPEXR and CAIIU have similar daily volatility (0.00).Check CAIIU's competition here
IPEXR vs HACQ Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, HACQ has a market cap of 287.5M. Regarding current trading prices, IPEXR is priced at $0.66, while HACQ trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HACQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to HACQ's ROE of N/A. Regarding short-term risk, IPEXR and HACQ have similar daily volatility (0.00).Check HACQ's competition here
IPEXR vs KPET Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, KPET has a market cap of 287.5M. Regarding current trading prices, IPEXR is priced at $0.66, while KPET trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas KPET's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to KPET's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to KPET. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check KPET's competition here
IPEXR vs ACAAU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ACAAU has a market cap of 287.3M. Regarding current trading prices, IPEXR is priced at $0.66, while ACAAU trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ACAAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ACAAU's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to ACAAU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ACAAU's competition here
IPEXR vs XCBE Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, XCBE has a market cap of 280.1M. Regarding current trading prices, IPEXR is priced at $0.66, while XCBE trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas XCBE's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to XCBE's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to XCBE. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check XCBE's competition here
IPEXR vs XSLL Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, XSLL has a market cap of 274.3M. Regarding current trading prices, IPEXR is priced at $0.66, while XSLL trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas XSLL's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to XSLL's ROE of +0.00%. Regarding short-term risk, IPEXR and XSLL have similar daily volatility (0.00).Check XSLL's competition here
IPEXR vs HVII Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, HVII has a market cap of 271.3M. Regarding current trading prices, IPEXR is priced at $0.66, while HVII trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HVII's P/E ratio is 86.88. In terms of profitability, IPEXR's ROE is +0.02%, compared to HVII's ROE of +0.02%. Regarding short-term risk, IPEXR is less volatile compared to HVII. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check HVII's competition here
IPEXR vs GIXXU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, GIXXU has a market cap of 269M. Regarding current trading prices, IPEXR is priced at $0.66, while GIXXU trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas GIXXU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to GIXXU's ROE of +0.00%. Regarding short-term risk, IPEXR and GIXXU have similar daily volatility (0.00).Check GIXXU's competition here
IPEXR vs FACTU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, FACTU has a market cap of 266.9M. Regarding current trading prices, IPEXR is priced at $0.66, while FACTU trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas FACTU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to FACTU's ROE of +0.03%. Regarding short-term risk, IPEXR and FACTU have similar daily volatility (0.00).Check FACTU's competition here
IPEXR vs SORN Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SORN has a market cap of 261.3M. Regarding current trading prices, IPEXR is priced at $0.66, while SORN trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SORN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SORN's ROE of +1.43%. Regarding short-term risk, IPEXR and SORN have similar daily volatility (0.00).Check SORN's competition here
IPEXR vs MLAA Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, MLAA has a market cap of 258.9M. Regarding current trading prices, IPEXR is priced at $0.66, while MLAA trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MLAA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MLAA's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to MLAA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MLAA's competition here
IPEXR vs ALOV Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ALOV has a market cap of 258.9M. Regarding current trading prices, IPEXR is priced at $0.66, while ALOV trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ALOV's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ALOV's ROE of +0.01%. Regarding short-term risk, IPEXR and ALOV have similar daily volatility (0.00).Check ALOV's competition here
IPEXR vs PLMK Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PLMK has a market cap of 258.4M. Regarding current trading prices, IPEXR is priced at $0.66, while PLMK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PLMK's P/E ratio is 42.64. In terms of profitability, IPEXR's ROE is +0.02%, compared to PLMK's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to PLMK. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PLMK's competition here
IPEXR vs HVIIU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, HVIIU has a market cap of 258.3M. Regarding current trading prices, IPEXR is priced at $0.66, while HVIIU trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HVIIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to HVIIU's ROE of +0.02%. Regarding short-term risk, IPEXR and HVIIU have similar daily volatility (0.00).Check HVIIU's competition here
IPEXR vs AACI Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, AACI has a market cap of 253.9M. Regarding current trading prices, IPEXR is priced at $0.66, while AACI trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas AACI's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to AACI's ROE of +0.00%. Regarding short-term risk, IPEXR and AACI have similar daily volatility (0.00).Check AACI's competition here
IPEXR vs PTOR Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PTOR has a market cap of 252.9M. Regarding current trading prices, IPEXR is priced at $0.66, while PTOR trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PTOR's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PTOR's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to PTOR. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PTOR's competition here
IPEXR vs DMAAU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, DMAAU has a market cap of 250.5M. Regarding current trading prices, IPEXR is priced at $0.66, while DMAAU trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DMAAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DMAAU's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to DMAAU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DMAAU's competition here
IPEXR vs HCICU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, HCICU has a market cap of 250.4M. Regarding current trading prices, IPEXR is priced at $0.66, while HCICU trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HCICU's P/E ratio is 43.30. In terms of profitability, IPEXR's ROE is +0.02%, compared to HCICU's ROE of -0.78%. Regarding short-term risk, IPEXR and HCICU have similar daily volatility (0.00).Check HCICU's competition here
IPEXR vs OIMAW Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, IPEXR is priced at $0.66, while OIMAW trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas OIMAW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to OIMAW's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to OIMAW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check OIMAW's competition here
IPEXR vs CAQ Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CAQ has a market cap of 247.3M. Regarding current trading prices, IPEXR is priced at $0.66, while CAQ trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CAQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CAQ's ROE of +9.93%. Regarding short-term risk, IPEXR and CAQ have similar daily volatility (0.00).Check CAQ's competition here
IPEXR vs SAAQ Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SAAQ has a market cap of 247.1M. Regarding current trading prices, IPEXR is priced at $0.66, while SAAQ trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAAQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAAQ's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to SAAQ. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SAAQ's competition here
IPEXR vs HCIC Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, HCIC has a market cap of 245.7M. Regarding current trading prices, IPEXR is priced at $0.66, while HCIC trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HCIC's P/E ratio is 29.12. In terms of profitability, IPEXR's ROE is +0.02%, compared to HCIC's ROE of -2571.52%. Regarding short-term risk, IPEXR and HCIC have similar daily volatility (0.00).Check HCIC's competition here
IPEXR vs SBXE-UN Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SBXE-UN has a market cap of 242.6M. Regarding current trading prices, IPEXR is priced at $0.66, while SBXE-UN trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SBXE-UN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SBXE-UN's ROE of -0.03%. Regarding short-term risk, IPEXR and SBXE-UN have similar daily volatility (0.00).Check SBXE-UN's competition here
IPEXR vs DRDB Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, DRDB has a market cap of 242.4M. Regarding current trading prices, IPEXR is priced at $0.66, while DRDB trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DRDB's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DRDB's ROE of +0.02%. Regarding short-term risk, IPEXR is less volatile compared to DRDB. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DRDB's competition here
IPEXR vs SSACU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SSACU has a market cap of 241.4M. Regarding current trading prices, IPEXR is priced at $0.66, while SSACU trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SSACU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SSACU's ROE of -0.05%. Regarding short-term risk, IPEXR and SSACU have similar daily volatility (0.00).Check SSACU's competition here
IPEXR vs IRHO Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, IRHO has a market cap of 237.3M. Regarding current trading prices, IPEXR is priced at $0.66, while IRHO trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas IRHO's P/E ratio is 251.75. In terms of profitability, IPEXR's ROE is +0.02%, compared to IRHO's ROE of +1.87%. Regarding short-term risk, IPEXR and IRHO have similar daily volatility (0.00).Check IRHO's competition here
IPEXR vs AACO Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, AACO has a market cap of 234.3M. Regarding current trading prices, IPEXR is priced at $0.66, while AACO trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas AACO's P/E ratio is -3090.62. In terms of profitability, IPEXR's ROE is +0.02%, compared to AACO's ROE of +0.00%. Regarding short-term risk, IPEXR and AACO have similar daily volatility (0.00).Check AACO's competition here
IPEXR vs ILLU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ILLU has a market cap of 233.9M. Regarding current trading prices, IPEXR is priced at $0.66, while ILLU trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ILLU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ILLU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to ILLU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ILLU's competition here
IPEXR vs VHCP Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, VHCP has a market cap of 230.2M. Regarding current trading prices, IPEXR is priced at $0.66, while VHCP trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas VHCP's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to VHCP's ROE of N/A. Regarding short-term risk, IPEXR and VHCP have similar daily volatility (0.00).Check VHCP's competition here
IPEXR vs LPCV Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, LPCV has a market cap of 230M. Regarding current trading prices, IPEXR is priced at $0.66, while LPCV trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas LPCV's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to LPCV's ROE of +0.00%. Regarding short-term risk, IPEXR and LPCV have similar daily volatility (0.00).Check LPCV's competition here
IPEXR vs ITHA Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ITHA has a market cap of 230M. Regarding current trading prices, IPEXR is priced at $0.66, while ITHA trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ITHA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ITHA's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to ITHA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ITHA's competition here
IPEXR vs ADAC Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ADAC has a market cap of 230M. Regarding current trading prices, IPEXR is priced at $0.66, while ADAC trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ADAC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ADAC's ROE of +0.01%. Regarding short-term risk, IPEXR and ADAC have similar daily volatility (0.00).Check ADAC's competition here
IPEXR vs BLRK Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, BLRK has a market cap of 230M. Regarding current trading prices, IPEXR is priced at $0.66, while BLRK trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BLRK's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BLRK's ROE of N/A. Regarding short-term risk, IPEXR and BLRK have similar daily volatility (0.00).Check BLRK's competition here
IPEXR vs XCBEU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, XCBEU has a market cap of 228.8M. Regarding current trading prices, IPEXR is priced at $0.66, while XCBEU trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas XCBEU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to XCBEU's ROE of N/A. Regarding short-term risk, IPEXR and XCBEU have similar daily volatility (0.00).Check XCBEU's competition here
IPEXR vs MEVOU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, MEVOU has a market cap of 227.3M. Regarding current trading prices, IPEXR is priced at $0.66, while MEVOU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MEVOU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MEVOU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to MEVOU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MEVOU's competition here
IPEXR vs DRDBU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, DRDBU has a market cap of 222.8M. Regarding current trading prices, IPEXR is priced at $0.66, while DRDBU trades at $11.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DRDBU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DRDBU's ROE of +0.02%. Regarding short-term risk, IPEXR and DRDBU have similar daily volatility (0.00).Check DRDBU's competition here
IPEXR vs PTORU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PTORU has a market cap of 221.8M. Regarding current trading prices, IPEXR is priced at $0.66, while PTORU trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PTORU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PTORU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to PTORU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PTORU's competition here
IPEXR vs SVAQ Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SVAQ has a market cap of 221.6M. Regarding current trading prices, IPEXR is priced at $0.66, while SVAQ trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SVAQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SVAQ's ROE of +0.01%. Regarding short-term risk, IPEXR and SVAQ have similar daily volatility (0.00).Check SVAQ's competition here
IPEXR vs IACQU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, IACQU has a market cap of 220.9M. Regarding current trading prices, IPEXR is priced at $0.66, while IACQU trades at $10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas IACQU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to IACQU's ROE of N/A. Regarding short-term risk, IPEXR and IACQU have similar daily volatility (0.00).Check IACQU's competition here
IPEXR vs GIX Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, GIX has a market cap of 218.6M. Regarding current trading prices, IPEXR is priced at $0.66, while GIX trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas GIX's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to GIX's ROE of +2.26%. Regarding short-term risk, IPEXR and GIX have similar daily volatility (0.00).Check GIX's competition here
IPEXR vs ACGC Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ACGC has a market cap of 217.9M. Regarding current trading prices, IPEXR is priced at $0.66, while ACGC trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ACGC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ACGC's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to ACGC. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ACGC's competition here
IPEXR vs NHIVU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, NHIVU has a market cap of 210.2M. Regarding current trading prices, IPEXR is priced at $0.66, while NHIVU trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NHIVU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to NHIVU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to NHIVU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check NHIVU's competition here
IPEXR vs MUZEU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, MUZEU has a market cap of 210.1M. Regarding current trading prices, IPEXR is priced at $0.66, while MUZEU trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MUZEU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MUZEU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to MUZEU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MUZEU's competition here
IPEXR vs TRGSU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, TRGSU has a market cap of 209.2M. Regarding current trading prices, IPEXR is priced at $0.66, while TRGSU trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TRGSU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TRGSU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to TRGSU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check TRGSU's competition here
IPEXR vs GSRVU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, GSRVU has a market cap of 206.3M. Regarding current trading prices, IPEXR is priced at $0.66, while GSRVU trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas GSRVU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to GSRVU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to GSRVU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check GSRVU's competition here
IPEXR vs TRGS Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, TRGS has a market cap of 206.1M. Regarding current trading prices, IPEXR is priced at $0.66, while TRGS trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TRGS's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TRGS's ROE of N/A. Regarding short-term risk, IPEXR and TRGS have similar daily volatility (0.00).Check TRGS's competition here
IPEXR vs WLII Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, WLII has a market cap of 205.3M. Regarding current trading prices, IPEXR is priced at $0.66, while WLII trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas WLII's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to WLII's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to WLII. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check WLII's competition here
IPEXR vs MUZE Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, MUZE has a market cap of 204.9M. Regarding current trading prices, IPEXR is priced at $0.66, while MUZE trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MUZE's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MUZE's ROE of N/A. Regarding short-term risk, IPEXR and MUZE have similar daily volatility (0.00).Check MUZE's competition here
IPEXR vs SAC-UN Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SAC-UN has a market cap of 204.8M. Regarding current trading prices, IPEXR is priced at $0.66, while SAC-UN trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAC-UN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAC-UN's ROE of +0.00%. Regarding short-term risk, IPEXR and SAC-UN have similar daily volatility (0.00).Check SAC-UN's competition here
IPEXR vs IDACU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, IDACU has a market cap of 201.4M. Regarding current trading prices, IPEXR is priced at $0.66, while IDACU trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas IDACU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to IDACU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to IDACU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check IDACU's competition here
IPEXR vs QADR Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, QADR has a market cap of 198.5M. Regarding current trading prices, IPEXR is priced at $0.66, while QADR trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas QADR's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to QADR's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to QADR. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check QADR's competition here
IPEXR vs DYNCW Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, DYNCW has a market cap of 186.4M. Regarding current trading prices, IPEXR is priced at $0.66, while DYNCW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DYNCW's P/E ratio is -0.16. In terms of profitability, IPEXR's ROE is +0.02%, compared to DYNCW's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to DYNCW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DYNCW's competition here
IPEXR vs AACPU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, AACPU has a market cap of 181.4M. Regarding current trading prices, IPEXR is priced at $0.66, while AACPU trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas AACPU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to AACPU's ROE of +0.00%. Regarding short-term risk, IPEXR and AACPU have similar daily volatility (0.00).Check AACPU's competition here
IPEXR vs ETHM Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, ETHM has a market cap of 178.8M. Regarding current trading prices, IPEXR is priced at $0.66, while ETHM trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ETHM's P/E ratio is -13.46. In terms of profitability, IPEXR's ROE is +0.02%, compared to ETHM's ROE of +0.17%. Regarding short-term risk, IPEXR is less volatile compared to ETHM. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ETHM's competition here
IPEXR vs BREZU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, BREZU has a market cap of 177.4M. Regarding current trading prices, IPEXR is priced at $0.66, while BREZU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BREZU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BREZU's ROE of +0.53%. Regarding short-term risk, IPEXR is less volatile compared to BREZU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BREZU's competition here
IPEXR vs SCII Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SCII has a market cap of 175.8M. Regarding current trading prices, IPEXR is priced at $0.66, while SCII trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SCII's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SCII's ROE of N/A. Regarding short-term risk, IPEXR and SCII have similar daily volatility (0.00).Check SCII's competition here
IPEXR vs PAAC Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PAAC has a market cap of 174.9M. Regarding current trading prices, IPEXR is priced at $0.66, while PAAC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PAAC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PAAC's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to PAAC. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PAAC's competition here
IPEXR vs SUMA Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SUMA has a market cap of 174.5M. Regarding current trading prices, IPEXR is priced at $0.66, while SUMA trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SUMA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SUMA's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to SUMA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SUMA's competition here
IPEXR vs IRAB Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, IRAB has a market cap of 171.5M. Regarding current trading prices, IPEXR is priced at $0.66, while IRAB trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas IRAB's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to IRAB's ROE of -0.14%. Regarding short-term risk, IPEXR is less volatile compared to IRAB. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check IRAB's competition here
IPEXR vs PALO Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, PALO has a market cap of 168.8M. Regarding current trading prices, IPEXR is priced at $0.66, while PALO trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PALO's P/E ratio is -3206.45. In terms of profitability, IPEXR's ROE is +0.02%, compared to PALO's ROE of -0.01%. Regarding short-term risk, IPEXR is less volatile compared to PALO. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PALO's competition here
IPEXR vs CTAAU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, CTAAU has a market cap of 167.7M. Regarding current trading prices, IPEXR is priced at $0.66, while CTAAU trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CTAAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CTAAU's ROE of +0.00%. Regarding short-term risk, IPEXR and CTAAU have similar daily volatility (0.00).Check CTAAU's competition here
IPEXR vs SVCCU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SVCCU has a market cap of 166.1M. Regarding current trading prices, IPEXR is priced at $0.66, while SVCCU trades at $10.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SVCCU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SVCCU's ROE of +0.04%. Regarding short-term risk, IPEXR and SVCCU have similar daily volatility (0.00).Check SVCCU's competition here
IPEXR vs SAGU Comparison June 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 183.7M. In comparison, SAGU has a market cap of 159.7M. Regarding current trading prices, IPEXR is priced at $0.66, while SAGU trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAGU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAGU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to SAGU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SAGU's competition here